{"url":"https://www.eagletribune.com/news/boston/insiders-look-under-the-hood-at-health-care-cost-drivers/article_e460751c-e0f7-466d-841c-369cbb42df84.html","title":"Shift to Costlier Care Drives Mass. Health Spending Surge","domain":"eagletribune.com","imageUrl":"https://images.pexels.com/photos/47327/medications-money-cure-tablets-47327.jpeg?auto=compress&cs=tinysrgb&h=650&w=940","category":"Tech","language":"en","slug":"4d8a22c1","id":"4d8a22c1-10b5-4a3b-92fd-71b0fe62743a","description":"Health Policy Commission hearing reveals shifts to costlier care settings drive Massachusetts health spending rise.","summary":"## TL;DR\n- **Health Policy Commission** hearing reveals shifts to costlier care settings drive Massachusetts health spending rise.\n- Commercial spending grew **8.8%** from **2022-2024**, less than half from price increases alone.\n- Benchmark exceeded four years running, pushing reforms to control costs.\n\n## The story at a glance\n**David Auerbach** of the **Health Policy Commission** presented data at the annual cost growth benchmark hearing on **April 1, 2026**, showing utilization shifts—not just prices—fuel health care spending growth in **Massachusetts**. Regulators, lawmakers, and business leaders discussed revising the **2012** benchmark, exceeded for four years. This comes as per capita spending rose **5.7%** in **2023-2024** against a **3.6%** target.[[1]](https://www.wwlp.com/news/massachusetts/insiders-look-under-the-hood-at-health-care-cost-drivers)[[2]](https://www.yahoo.com/news/articles/insiders-look-under-hood-health-005027693.html)\n\n## Key moments & milestones\n- **2012**: **Health Policy Commission** establishes cost growth benchmark law.\n- **2022-2024**: Commercial health spending increases **8.8%**.\n- **2023-2024**: Total per capita spending grows **5.7%**, exceeding **3.6%** benchmark.\n- **April 1, 2026**: **David Auerbach** presents data at **HPC** hearing on cost drivers.\n- **April 16, 2026**: **HPC** board to vote on new benchmark target.\n\n## Signature highlights\n- Shift to pricier care sites: Colonoscopies cost **$2,600** in hospital outpatient vs. **$1,600** ambulatory surgical centers and **$980** offices.\n- **GLP-1 drugs** and drugs over **$1,000**/dose drove prescription spending; uptake rose **2020-2024**.\n- Hospital high-severity admissions nearly doubled **2016-2025**, mainly from coding changes, not acuity.\n- Chemo oncology drugs hit **$3 billion** annually, driven by manufacturer prices and provider site fees.\n- Small business family premiums average **$47,000**; state mandates add **$8,000-$11,000** (**17-24%**).\n- Recent retailer survey: Average premium hikes **13.6%**.\n\n## Key quotes\n- \"**We see shifts toward higher priced prescription drugs, shifts toward higher-cost imaging modalities, shifts toward higher-cost settings of care for colonoscopy for routine screenings**,\" **David Auerbach**, **Health Policy Commission**.[[1]](https://www.wwlp.com/news/massachusetts/insiders-look-under-the-hood-at-health-care-cost-drivers)\n- \"The state is at a **breaking point of complete unaffordable health care**,\" **Rep. John Lawn**, Joint Committee on Health Care Financing co-chair.[[1]](https://www.wwlp.com/news/massachusetts/insiders-look-under-the-hood-at-health-care-cost-drivers)\n- \"**The incentive was to figure out what I am doing that has the highest margin possible so I can keep paying my employees**,\" **Kiame Mahaniah**, Health and Human Services Secretary.[[1]](https://www.wwlp.com/news/massachusetts/insiders-look-under-the-hood-at-health-care-cost-drivers)\n\n## Why it matters\nRising costs beyond benchmarks strain **Massachusetts** health system affordability amid federal changes. Patients face higher premiums and delay care; businesses see **13.6%** hikes, small firms hit by **$47,000** family plans plus mandates. Watch **April 16** **HPC** vote and potential legislative hearing on benchmark revisions.","hashtags":["#healthcare","#massachusetts","#costs","#policy","#insurance","#drugs"],"viewCount":2,"publishedAt":"2026-04-04T18:33:22.029Z"}